📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Sirnaomics

1.1 - Company Overview

Sirnaomics Logo

Sirnaomics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of RNA interference-based therapeutics and delivery platforms. Develops STP705, an siRNA targeting TGF-β1 and COX-2 for non-melanoma skin cancer, cholangiocarcinoma, and hypertrophic scars; RNAi prophylactics and therapeutics for severe acute respiratory infection caused by 2019-nCoV; and delivery technologies including a polypeptide nanoparticle platform for mRNA vaccines/therapeutics and a GalNAc platform for liver-targeted RNAi.

Products and services

  • STP705: A custom-engineered siRNA therapeutic that suppresses TGF-β1 and COX-2 gene expression, for treating non-melanoma skin cancer, cholangiocarcinoma, and hypertrophic scars
  • GalNAc Delivery Platform: A modular platform enabling systemic administration of liver-targeting RNAi therapeutics, engineered to deliver RNA interference drugs to the liver via GalNAc
  • Polypeptide Nanoparticle Delivery Platform (PNP): A scalable delivery system for mRNA vaccines and therapeutics, enhancing the delivery of RNA-based drugs through polypeptide nanoparticle assemblies

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Sirnaomics

Plasma-Therm Logo

Plasma-Therm

HQ: United States Website
  • Description: Provider of etch and thin film deposition equipment and configurable wafer processing platforms for global compound semiconductor and related specialty markets. Offerings include plasma etch, thin film deposition, rapid thermal processing, plasma dicing, die singulation, and Tegal Diode RIE systems. U.S.-based, with over 35 years enabling process technologies and 24 patents in plasma process.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Plasma-Therm company profile →
Nanotech Security Logo

Nanotech Security

HQ: Canada Website
  • Description: Provider of nanotechnology-based optical security products and devices, including KolourOptik currency authentication and anti-counterfeiting technology, LiveOptik brand protection solutions, government and banknote security for Central Banks and ID documents using optical technologies, and brand protection foils, labels, and IoT solutions with distinctive visual effects.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nanotech Security company profile →
Hybrid Plastics Logo

Hybrid Plastics

HQ: United States Website
  • Description: Provider of polyhedral oligomeric silsesquioxane (POSS) materials and chemical additives for commercial production and R&D. Hybrid Plastics manufactures and supplies POSS, nanosilica dispersions, optical hard coatings, flow and dispersion aids, lubricants, and adhesives, enhancing mechanical properties and performance across coatings, plastics, and composites, and operating as a research and development catalyst.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Hybrid Plastics company profile →
Zynerba Pharmaceuticals Logo

Zynerba Pharmaceuticals

HQ: United States Website
  • Description: Provider of innovative transdermal cannabinoid treatments for neuropsychiatric disorders, developing proprietary dermal solutions and therapeutic candidates using modern drug delivery technology. Offers Zygel (ZYN002 cannabidiol gel) for Fragile X syndrome and 22q11.2 deletion syndrome, and conducts clinical trials across various countries to assess its safety and efficacy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Zynerba Pharmaceuticals company profile →
Berkeley Design Automation Logo

Berkeley Design Automation

HQ: United States Website
  • Description: Provider of nanometer circuit verification for analog, mixed-signal, RF, and custom digital designs, used by over 100 semiconductor companies worldwide to verify complex IC products and overcome traditional verification barriers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Berkeley Design Automation company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Sirnaomics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Sirnaomics

2.2 - Growth funds investing in similar companies to Sirnaomics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Sirnaomics

4.2 - Public trading comparable groups for Sirnaomics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Sirnaomics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Sirnaomics

What does Sirnaomics do?

Sirnaomics is a provider of RNA interference-based therapeutics and delivery platforms. Develops STP705, an siRNA targeting TGF-β1 and COX-2 for non-melanoma skin cancer, cholangiocarcinoma, and hypertrophic scars; RNAi prophylactics and therapeutics for severe acute respiratory infection caused by 2019-nCoV; and delivery technologies including a polypeptide nanoparticle platform for mRNA vaccines/therapeutics and a GalNAc platform for liver-targeted RNAi.

Who are Sirnaomics's competitors?

Sirnaomics's competitors and similar companies include Plasma-Therm, Nanotech Security, Hybrid Plastics, Zynerba Pharmaceuticals, and Berkeley Design Automation.

Where is Sirnaomics headquartered?

Sirnaomics is headquartered in United States.

How many employees does Sirnaomics have?

Sirnaomics has 1,000 employees 🔒.

When was Sirnaomics founded?

Sirnaomics was founded in 2010 🔒.

What sector and industry vertical is Sirnaomics in?

Sirnaomics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Sirnaomics

Who are the top strategic acquirers in Sirnaomics's sector and industry

Top strategic M&A buyers and acquirers in Sirnaomics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Sirnaomics?

Top strategic M&A buyers groups and sectors for Sirnaomics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Sirnaomics's sector and industry vertical

Which are the top PE firms investing in Sirnaomics's sector and industry vertical?

Top PE firms investing in Sirnaomics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Sirnaomics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Sirnaomics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Sirnaomics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Sirnaomics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Sirnaomics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Sirnaomics?

The key public trading comparables and valuation benchmarks for Sirnaomics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Sirnaomics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Sirnaomics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Sirnaomics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Sirnaomics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Sirnaomics's' sector and industry vertical?

Access recent funding rounds and capital raises in Sirnaomics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Sirnaomics

Launch login modal Launch register modal